Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00301405 · ClinicalTrials.gov registry record · Phase 2
Open-Label Study of Thalidomide for Chronic Prostatitis/Chronic Pelvic Pain
A Phase 2 study, sponsored by Kenneth Peters, MD.
- Terminated
- Registry status
- Phase 2
- Development phase
- 9
- Enrollment target
NCT00301405: Clinical Trial Phase 2 study, sponsored by Kenneth Peters, MD.
NCT00301405 is a Phase 2 study that was terminated before completion, run by Kenneth Peters, MD. The registered enrollment target is 9 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00301405, a Phase 2 study, was terminated before completion, sponsored by Kenneth Peters, MD.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 9 participants
- Enrollment target
Study Summary
To determine the efficacy of thalidomide for treatment of the Chronic Pelvic Pain Syndrome (CPPS).
Interventions
- DRUG Thalidomide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2006-03 |
| Est. Completion | 2006-11 |
| Phase | Phase 2 |
Why NCT00301405 stopped before completion
NCT00301405 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 1 intervention - of which Thalidomide is the first listed.
NCT00301405 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00301405 about?
NCT00301405 is a clinical study titled "Open-Label Study of Thalidomide for Chronic Prostatitis/Chronic Pelvic Pain". To determine the efficacy of thalidomide for treatment of the Chronic Pelvic Pain Syndrome (CPPS).
What is the current status of trial NCT00301405?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 9 participants. The study started on 2006-03. Estimated completion is 2006-11.
What interventions are being tested in trial NCT00301405?
The interventions under investigation include: Thalidomide (DRUG).
Who is sponsoring clinical trial NCT00301405?
This trial is sponsored by Kenneth Peters, MD, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00301405's enrollment target sits among peer trials
9 1989th of 2000 higher than 11 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia